LivingGLP1
Study S002457

A Prospective Decision Impact Trial of KidneyIntelX in Patients With Type 2 Diabetes and Existing Chronic Kidney Disease

ClinicalTrials.gov record

Registration

Registration
NCT04960514
Study type
OBSERVATIONAL
Status
ACTIVE_NOT_RECRUITING
Enrollment
2000
Start
2021-11-22
Primary completion
2023-12-01
Lead sponsor
Renalytix AI, Inc.
Conditions
Diabetic Kidney Disease; Chronic Kidney Disease Stage 1; Chronic Kidney Disease Stage 2; Chronic Kidney Disease, Stage 3 (Moderate)
Interventions
DIAGNOSTIC_TEST:KidneyIntelX
Results posted
FALSE
Individual participant data sharing
UNDECIDED

Registered primary outcomes

  • Blood pressure [12 Months]
  • HbA1c [12 Months]
  • ACEi/ARB [12 Months]
  • SGLT2/ GLP1 [12 Months]
  • Urine albumin to creatinine ratio [12 Months]
  • Referrals [12 Months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.